Inspire Medical Systems Inc Q2 2022 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Great. Congrats on a really nice quarter.

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Maybe to start, once again, you've put up really nice utilization, good news center growth. Anyway now that you're couple quarters into your national advertising program, it's about a year since the CPAP recall came in, anyway to put some metrics around how the national program is impacting numbers? If you have any metrics you could share and anyway to size up the CPAP recall at this point, and how much of a tailwind do you think is left there?

Question: Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst : Great. Maybe as a follow-up, when we do doc checks, they love the product. There's still a ton of room to go in terms of utilization at the centers, but many years down the road, one of the things we consistently hear is that, there's only so many docs who could do this and they only have so many hours in the day. So how should we think about Inspire V as increasing the available capacity within the system? How much can that open-up with the shorter procedure and anything else you can do to keep capacity, not the issue going forward? Thanks a lot.